Today, the Honourable Marjorie Michel, Minister of Health, announced the designation of a new Chairperson for the Patented Medicine Prices Review Board (PMPRB).
Anie Perrault, a member of the PMPRB, was designated as Chairperson until August 9, 2028. Ms. Perrault, a lawyer by training with more than 30 years of professional experience in the public and private sector, was previously designated Vice-Chairperson of the Board in August 2023. Ms. Perrault will continue to be supported by Board members Dr. Emily Reynen, Mr. Peter Moreland-Giraldeau and Ms. Sharon Blady.
The PMPRB is an arm's-length organization of the government, that protects the interests of Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive.
The Government of Canada is committed to appointing highly-qualified candidates to best serve the interests of Canadians and is committed to open, transparent, and merit-based processes for selecting Governor in Council appointees. Appointees play a fundamental role in Canadian democracy as they serve on commissions, boards, Crown corporations, agencies and tribunals across the country.
